Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Nutrition ; 62: 93-99, 2019 06.
Article in English | MEDLINE | ID: mdl-30856400

ABSTRACT

OBJECTIVES: Breastfeeding rates in many countries fall short of the World Health Organization's recommendations. It has been reported that exclusive breastfeeding (EBF) is negatively associated with obesity; however, the association varies with ethnicity, and little information is available from Asia. We explored whether prepregnancy body mass index (BMI) and gestational weight gain (GWG) were associated with initiation of EBF. METHODS: We investigated 6125 Japanese women with full-term (37-42 wk of gestation) singleton babies between January 2010 and June 2013, in a hospital with the largest annual number of deliveries in Tokyo, Japan. RESULTS: Successful EBF initiation was observed in 72% of women 1 mo after delivery. The average GWG was 10 kg in underweight (BMI < 18.5 kg/m2) and normal weight (BMI 18.5-24.9 kg/m2) women; 7 kg in overweight (BMI 25-29.9 kg/m2) women, and 4 kg in obese (BMI ≥ 30 kg/m2) women. After adjusting for covariates, stepwise modeling revealed that compared with women of normal weight, obesity (odds ratio [OR], 0.29; 95% confidence interval [CI], 0.16-0.53), and a single-unit increase in the GWG (OR, 0.98; 95% CI, 0.96-1.00) were significantly associated with unsuccessful EBF initiation. No statistical interaction was evident between prepregnancy BMI and GWG. Other significant risk factors for unsuccessful EBF initiation included older maternal age (P < 0.001), nulliparity (P < 0.001), cesarean delivery (P < 0.001), an earlier gestational week (P < 0.001), a light-for-date infant (P < 0.05), and mother-child separation for clinical reasons (P < 0.001). CONCLUSIONS: This study suggested that prepregnancy obesity is a risk factor for EBF initiation among Japanese women.


Subject(s)
Breast Feeding/statistics & numerical data , Obesity/epidemiology , Adult , Body Mass Index , Cohort Studies , Female , Humans , Japan/epidemiology , Retrospective Studies , Risk Factors
2.
Sci Rep ; 7(1): 2569, 2017 05 31.
Article in English | MEDLINE | ID: mdl-28566718

ABSTRACT

This study aims to compare the US Institute of Medicine (IOM) and Japanese guidelines proposed by the Ministry and the Japan Society for the Study of Obesity on gestational weight gain (GWG), and to explore the optimal GWG range in Japanese women. We investigated 8,152 Japanese women who had full-term singleton babies between 2010 and 2013 at a single center in Tokyo. Logistic regression models showed that GWG below the recommendation of the IOM and Japanese guidelines was similarly associated with an increased risk of light-for-date (LFD), whereas GWG above these guidelines was similarly associated with an increased risk of heavy-for-date (HFD) in pre-pregnancy body mass index categories of underweight (<18.5 kg/m2, n = 1559), normal-weight (18.5-24.9 kg/m2, n = 4998), overweight (25.0-29.9 kg/m2, n = 270), and obese (30 ≤ kg/m2, n = 60). The receiver-operating characteristic curve demonstrated that the optimal cutoffs for LFD and HFD were 9.7 and 10.4 kg, respectively in normal-weight mothers. The IOM and Japanese guidelines identified the risk of LFD or HFD equally well. The optimal GWG range in normal-weight women observed in this study was more close to Japanese guideline (i.e., 7-12 kg) compared to the IOM guideline (i.e., 11.5-16 kg).


Subject(s)
Obesity/epidemiology , Overweight/epidemiology , Weight Gain/physiology , Adult , Body Mass Index , Female , Humans , Infant, Newborn , Japan/epidemiology , Mothers , Obesity/physiopathology , Overweight/physiopathology , Pregnancy , United States/epidemiology
3.
Ind Health ; 54(6): 515-520, 2016 Dec 07.
Article in English | MEDLINE | ID: mdl-27476380

ABSTRACT

This study aimed to examine the effects of parity and pre-pregnancy body mass index (BMI) on low birth weight (LBW) infants among Japanese women. Participants included 1,518 mothers (mean age 34.0 years) of singleton full-term infants in 2011. The incidence of LBW infants was 7.5% in primiparous women with BMI<18.5 (Group A; n=239), 4.0% in multiparous women with BMI<18.5 (Group B; n=124), 6.0% in primiparous women with 18.5≤BMI<25 (Group C; n=715), and 1.8% in multiparous women with 18.5≤BMI<25 (Group D; n=440). A multivariable logistic regression model revealed that mothers in Group A were more likely to deliver a LBW infant [odds ratio (OR) 6.41, 95% confidence interval (CI), 2.65-15.49] than were mothers in Group D. Being both underweight (OR 1.8, 95% CI: 1.05-3.11) and primiparous (OR 3.41, 95% CI: 1.82-6.44) were independently associated with LBW infants. This study demonstrated that the characteristics of primiparous and underweight in mothers are additively associated with LBW infants.


Subject(s)
Body Mass Index , Infant, Low Birth Weight , Parity , Thinness/epidemiology , Adult , Female , Humans , Japan/epidemiology , Logistic Models , Nutritional Status , Odds Ratio , Pregnancy , Retrospective Studies , Risk Factors
4.
Jpn J Clin Oncol ; 45(9): 795-804, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26056327

ABSTRACT

Platinum agents are drugs used for various types of cancer. With increased frequency of administration of platinum agents, hypersensitivity reactions appear more frequently, occurring in over 25% of cases from the seventh cycle or second line onward. It then becomes difficult to conduct treatment using these agents. Various approaches have been investigated to address hypersensitivity reactions to platinum agents. Desensitization, which gradually increases the concentration of the anticancer drug considered to be the antigen until the target dosage, has been reported as being particularly effective, with a success rate of 80-100%. The aims of this paper are to present the current findings regarding hypersensitivity reactions to platinum agents and to discuss attempts of using desensitization against hypersensitivity reactions worldwide.


Subject(s)
Antineoplastic Agents/adverse effects , Desensitization, Immunologic , Drug Hypersensitivity/etiology , Organoplatinum Compounds/adverse effects , Antineoplastic Agents/therapeutic use , Dexamethasone/therapeutic use , Drug Hypersensitivity/drug therapy , Drug Hypersensitivity/epidemiology , Humans , Neoplasms/drug therapy , Organoplatinum Compounds/therapeutic use , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...